Greenspring Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-523
Closed -$257K 112
2022
Q1
$257K Hold
523
0.07% 89
2021
Q4
$242K Buy
+523
New +$220K 0.06% 101

Other funds holding ELV

Greenspring Advisors's ELV Position: Q2 2022 in Review

Greenspring Advisors sold out of Elevance Health (ELV) in Q2 2022, closing a stake of 523 shares — an estimated $257K sold.

Greenspring Advisors first reported a position in ELV in Q4 2021 and held it in 2 quarters. The position peaked at $257K in Q1 2022. 1,440 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

  • Greenspring Advisors reported no remaining Elevance Health position as of Q2 2022 after selling out during the quarter.
  • Greenspring Advisors sold 523 Elevance Health shares in Q2 2022, an estimated $257K.
  • Greenspring Advisors first reported a position in Elevance Health in Q4 2021 and held it in 2 quarters.
  • Greenspring Advisors's Elevance Health position peaked at $257K in Q1 2022.
  • 1,440 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on Greenspring Advisors's 13F filing for Q2 2022, filed 11 Jul 2022.